1. Huang K, Wang Y, Zhen Y, Li G, Wu X, Zhang N, Chen Z, Wu R.Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A..Thromb Res..2022.12;213.71-77.SCI |
2. Cheng X, Fu L, Ma J, Gu H, Chen Z, Zhao L, Wang X, Wu R..Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood Adv.2021.5(19).3799-3806. |
3. Ma Jie, Fu Lingling, Chen Zhenping, Gu Hao, Ma Jingyao, Wu Runhui*.High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study.Int J Hematol.2020.112(6).773-779.SCI |
4. 姚婉茹,张庆,周敏,唐凌,罗晓波,张宁宁,杨胜,王岩,丁平,蔡思雨,陈振萍,李晓静,吴润晖*.重型血友病A患儿关节出血与关节评估的相关性研究.中华实用儿科临床杂志.2020.03.197-200.核心期刊 |
5. Kun Huang, Zhenping Chen, Gang Li, Yingzi Zhen, Xinyi Wu, Ningning Zhang, Runhui Wu*.Bleeds and imaging scoring scales in relation to pharmacokinetics of coagulation factor VIII in Chinese pediatric patients with severe hemophilia A..Thrombosis research.2020.193.83-85.SCI |
6. Kun Huang, Gang Li, Yingzi Zhen, Xinyi Wu, Zhenping Chen, Runhui Wu*.Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study.haemophilia.2020.27.e287-290.SCI |
7. Hao Gu, Jie Ma, Zhenping Chen, Jing Wang, Rui Zhang, Runhui Wu⁎.Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.Gene.2018.672.45-49.SCI |
8. Tang, Ling; Xu, Weiqun; Li, Changgang; Hou, F; Feng, Xiaoqin; Wang, Huafang; Li, Xiaojing; Li, W; Liu, J; Sun, L; Wang, S; Jin, J; Fang, Q; Luke, Koon-Hung; Poon, Man-Chiu; Blanchette, Victor; Usuba, Koyo; Young, Nancy; WU, Runhui*.Describing the Quality of Life of Boys with Haemophilia in China: Results of a Multi-Center Study using the CHO-KLAT..Haemophilia.2018.24.113-119.SCI |
9. 2. X Cheng, P Li, Z Chen, N Zhang, Y Zhen, L Zhao, X Wang*, R WU*. .Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A..Haemophilia.2018.24.126-133.SCI |
10. Liwei Gao, Jianxin HE* and Runhui WU*.Severe congenital neutropenia associated with the ELANE gene in Chinese children: case report..Pediatr Invest.2018.2(1).59-61.SCI |
11. 吴润晖执笔.指南.标准.共识:中国儿童血友病专家指导意见(2017年).中国实用儿科杂志.2017.32(1).1-5.核心期刊 |
12. HU Di, Kang Huiying, Lv Yanqiu, Zhang Ningning, Tang Ling, Zhang Jishui, Wu Runhui*, Peng Yun*.Preliminary evaluation of altered brain microstructure in the emotion-cognition region in children with hemophilia A: a diffusional kurtosis imaging study..Hemophilia.2017.23.99-104.SCI |
13. 王凯、苏雁、张莉、廉红云、张蕊、吴润晖*.幼年粒单细胞白血病21例灵床及基因分析.中华实用儿科临床杂志.2016.31(3).190-193.核心期刊 |
14. Yao WR, Xiao Juan, Cheng Xiaoling, Feng Guoshuang, Li Changgang, Zhang Xinsheng, Hu Qun, Xu Weiqun, Sun Jing, Yang Rengchi, Li Xiaojing, Zhou Rongfu, Lian Shimei, Gu Jian, Wu Junde, Zhao Yongqiang, Wu Runhui*.The Efficacy of Recombinant FVIII low-dose prophylaxis in Chinese Pediatric Patients with severe hemophilia A: A retrospective analysis from the ReCARE study.Clinical and Applied Thrombosis/Hemostasis.2016.1(8).851.SCI |
15. 刘国青 唐凌 吴心怡 甄英姿 李刚 陈振萍 王岩 张宁宁 张纪水 于国霞 吴润晖*.重型血友病A患儿19例个体化初级预防治疗疗效分析.中华儿科杂志.2016.54(12).923-926.核心期刊 |
16. Chen Z, Guo Z, Ma J, Liu F, Gao C, Liu S, Wang A, Wu R*.STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia.Autoimmunity.2015.early online:1-8.1-8.SCI |
17. 魏沄沄,张利强 ,郑胡镛,刘晓荣,刘刚,方方,徐樨巍,吴润晖 *.儿童导管相关性静脉血栓的发生情况与危险因素.中华实用儿科临床杂志.2015.30(13).1019-1022.核心期刊 |
18. Zhou, J., Ding, Q., Chen, Z., Yang, H., Lin, L., & Wang, H., Wang X, Wu R..Risk factors associated with inhibitor development inChinese patients with haemophilia B.Haemophilia.2015.21(4).e286-293..SCI |
19. 苏雁、郑杰、张利强、张蕊、张莉、廉红云、吴润晖*.环孢素A治疗非输血依赖型儿童非重型再生障碍性贫血疗效分析.中国小儿血液与肿瘤.2015.20(1).27-31.核心期刊 |
20. Zhenping Chen*, Zhenxing Guo, Jie Ma, Jingyao Ma, Fuhong Liu, Runhui Wu*.Foxp3 methylation status in children with primary immune thrombocytopenia Human Immunology..Human Immunology.2014.75(11).1115-1119.SCI |
21. Wu, R., Wu, X., Zhang, N., Zhao, L., Zhang, J., & Luke, K. H., et al. .Joint disease status of severe and moderate haemophilia patients at the Beijing Children’s Hospital: early onset and rapid increasing severity of arthropathy in 90% of patients by 6 years of age.Haemophilia.2014.20(3).e227-230.SCI |
22. 刘夫红,陈振萍,马静瑶,魏沄沄,吴润晖*.FOXP3基因多态性与儿童ITP发病及进展的相关性研究.首都医科大学学报.2014.35(5).539-544.核心期刊 |
23. 唐凌 吴润晖 吴心怡 甄英姿 陈振萍 李刚 王岩 张宁宁 张纪水 彭芸.中国儿童血友病诊断现状——单中心13年417例儿童血友病数据分析.血栓与止血学.2014.20(3).97-101.核心期刊 |
24. Wu, R., Zhang, J., Sun, J., Zhou, M., Wu, J. S., & Li, N., et al. .Validation of Chinese version of the Canadian Hemophilia Outcomes-Kids'Life Assessment Tool(the CHO-KLAT).Haemophilia.2014.20(6).794-799.SCI |
25. 马静瑶、陈振萍、吴润晖*.促血小板生成素在儿童ITP发病及预后中的作用探讨.血栓与止血学.2014.20(2).49-52.核心期刊 |
26. 魏琪琪、李刚、唐凌、陈振萍、甄英姿、吴心怡、张宁宁、张纪水、于国霞、吴润晖*.儿童血友病A抑制物产生相关因素横断面分析.中华儿科杂志.2014.52(2).99-102.核心期刊 |
27. 李刚、吴润晖*、吴心怡、甄英姿、张宁宁、王岩、何雯雯、彭芸、Luke Koon-hung, Poon Man-chiu, Andrea Doria..重组人凝血因子IX预防性治疗中国儿童中、重型血友病B的单中心临床观察.中华实用儿科临床杂志.2013.28(15).1128-1130.核心期刊 |
28. 吴润晖*、吴心怡、张宁宁、赵磊、张纪水、甄英姿、彭芸。.血友病儿童长疗程小剂量次级预防治疗的单中心疗效观察.中华血液学杂志.2013.34(7).632-634.核心期刊 |
29. L. TANG, 吴润晖*, J . SUN, X. ZHANG, X. FENG, X. ZHANG, K.-H. LUKE and M.-C. POON.Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle inits execution: a multi-centre pilot study in China..Haemophilia.2013.19-1.27-34.SCI |
30. 马静瑶,吴润晖*.儿童免疫性血小板减少症的自然病程及临床预后影响因素.中国小儿血液与肿瘤杂志.2013.18-1.43-46.核心期刊 |
31. 马静瑶、吴润晖.免疫性血小板减少症患者血小板生发研究进展.中国小儿血液与肿瘤杂志.2012.17(1).35-39.核心期刊 |
32. 吴润晖, 张济水,Nancy Young*, et al. .Cross-cultural adaption of the CHOKLAT for boys with Hemophilia in rural and urban China. .Health and Quality of life Outcomes .2012.10.112.SCI |
33. 马静瑶,吴润晖*.免疫性血小板减少症患者血小板生发研究进展.中国小儿血液与肿瘤杂志.2012.17-1.35-39.核心期刊 |
34. 唐凌 吴润晖.儿童血友病预防治疗及其剂量选择.中华儿科杂志.2012.50(1).70-73.核心期刊 |
35. 马静瑶,吴润晖*.应用促血小板生成剂治疗儿童免疫性血小板减少症的研究进展.中国实验血液学杂志.2012.20-6.1513-1517.核心期刊 |
36. 张利强、马洁、苏雁、周翾、杨菁、张瑞东、吴润晖*.利妥昔单抗治疗儿童慢性及难治性免疫性血小板减少症8例疗效及安全性分析.中国实用儿科杂志.2012.27-6.460-461.核心期刊 |
37. 何雯雯,吴润晖*.按需治疗下中、重型血友病患儿关节及颅内出血现状(综述).中华儿科杂志.2012.50-8.636-638.核心期刊 |
38. 何雯雯、吴润晖*、吴心怡等.129例学龄前中间、重型血友病患儿出血和诊治的临床分析.中华血液学杂志.2012.33-5.420-422.核心期刊 |
39. Kuhne T, Berchtold W, Michaels LA, Wu R, Donato H, Espina B, et al..Newly diagnosed immune thrombocytopenia in children and adults, a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group..Haematologica.2011.92(12).1831-1837.SCI |
40. 吴润晖执笔.儿童血友病诊疗建议.中华儿科杂志.2011.49(3).193-195.核心期刊 |
41. 苏雁、吴润晖.儿童血友病合并颅内出血21 例临床分析.首都医科大学学报.2010.31(2).206-209.核心期刊 |
42. 段彦龙,吴润晖*,吴敏媛,张永红,石惠文,谢静.儿童特发性血小板减少性紫癜与前驱病史的临床分析.血栓与止血学杂志.2010.15 (4).164-166.核心期刊 |
43. 吴润晖,郑胡镛.儿童特发性血小板减少性紫癜治疗新进展.中国小儿血液与肿瘤杂志.2010.15(1).40-43.核心期刊 |
44. 吴润晖*,郑杰.儿童再生障碍性贫血的病因研究.中国小儿血液与肿瘤杂志.2009.14(2).49-51.核心期刊 |
45. 吴润晖*,吴心怡,冯涛张宁宁,马洁,吴敏媛.儿童血友病病人临床资料及现状分析.血栓与止血学.2008.14(3).116-120.核心期刊 |